Market Tracker

10/23 4:36pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

During the Trading Day
11.22 +0.16 / +1.45%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.19 -0.03 / -0.27%
 
Volume: 10.8K

Today’s Trading

Previous close11.06
Today’s open11.18
Day’s range11.06 - 11.54
Volume3,681,037
Average volume (3 months)6,139,562
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)+1.56%
Earnings growth (this year)-12.52%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book7.00

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc+1.45+4.74%
KPTIKaryopharm Therapeut...+1.54+4.58%
LGNDLigand Pharmaceutica...+3.44+6.79%
NLNKNewLink Genetics Cor...-0.80-2.01%
Data as of 3:59pm ET, 10/23/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$58.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts